Floatz logo

Envarsus Product

Disease Related To Solid Organ Transplantation

University of AlbertaUNKNOWNPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Disease Related To Solid Organ Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
The Second Hospital of Tangshan
Phase 4BBB
Angiotensin Ii
University of California, San Francisco
Phase 4BBB
Everolimus
Novartis Pharmaceuticals
Phase 3BB
Equine Atg
University Hospital, Toulouse
Phase 4BB
Noradrenaline
University of California, Los Angeles
Phase 4BB

View all 34 →

Same molecule, other indications

Envarsus Product is also rated in:

kidney failureActive
BB
Indicative · Phase 4
65 / 100
View asset →
cardiovascular disorderActive
B
Indicative · Phase 4
62 / 100
View asset →
abdominal obesity-metabolic syndromeActive
B
Indicative · Phase 4
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →